Rotella Capital Management, Inc. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$91,000
-34.1%
10,360
-48.4%
0.08%
-45.5%
Q3 2014$138,000
+29.0%
20,060
-1.6%
0.14%
+59.3%
Q2 2014$107,000
+87.7%
20,376
+80.8%
0.09%
-19.5%
Q4 2013$57,000
-6.6%
11,272
-8.0%
0.11%
-41.8%
Q2 2013$61,00012,2550.19%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders